Antidilution Protection. In the event the Company shall issue shares of the Common Stock pursuant to the transactions contemplated by the Option, then the Company shall issue to Summit an additional 400,000 shares of the Common Stock, or such other number of shares such that, after giving effect to the additional issuances, Summit will be the holder of four percent (4%) of the Company’s then issued and outstanding capital stock.
Appears in 2 contracts
Sources: Contribution Agreement (Xcorporeal, Inc.), Contribution Agreement (Xcorporeal, Inc.)